1976 Nobel Prize in Physiology or Medicine — Blumberg and Gajdusek: Australian Aborigines' Serum and the Disease of a New Guinea Tribe

What You'll Learn in This Article

Blumberg, who discovered the antigen that causes hepatitis B through large-scale screening of blood samples from diverse populations, and Gajdusek, who elucidated the delayed infection mechanism of a unique neurodegenerative disease in the mountain tribes of New Guinea — understand how the different approaches of these two researchers led to remarkable achievements, and how these discoveries laid the foundation for today's hepatitis B vaccine and liver cancer prevention, and our understanding of prions and mad cow disease.

A Story Different from Common Sense: Two Ways to Find Pathogens

Let's start with Blumberg's approach. From the early 1960s onward, he began performing large-scale analyses of blood samples from various races and ethnic groups, digging into the correlation between reactivity and susceptibility to disease. In this large-scale scan, he discovered the "Australian antigen" in the serum of Australian aborigines in 1964, and three years later, in 1967, he clarified the relationship of this antigen to the hepatitis B virus (HBV). Following this discovery, the Australian antigen was established as the standard marker for screening blood that could transmit hepatitis B. He then went on to analyze the distribution of HBV within the human population, showing that individuals who appear outwardly healthy can carry HBV and transmit the virus to others.

What makes this approach unique? It's not that he started by looking for a specific pathogen; instead, he conducted a large-scale scan of serum from various population groups and serendipitously discovered a new antigen. This is a very unusual approach to pathogen discovery. Usually, you start with the disease and then look for the cause, but Blumberg started with a large-scale scan of serum data and later linked it to the disease.

Gajdusek's approach was the opposite. He focused on a unique neurodegenerative disease called "kuru", which occurs only in the mountain tribes of New Guinea — a deep investigation into this strange disease to uncover its cause.

The kuru he elucidated was the first chronic degenerative disease shown to be caused by a slow-acting viral infection, in which patients gradually deteriorate over several years and eventually die. Slow-acting viruses cause a variety of chronic degenerative diseases and, decisively, they do not provoke an inflammatory response — unlike other viral infections. This kuru research turned out to be the trigger for research that later elucidated the causes of multiple sclerosis, Parkinson's disease, and numerous other unexplained degenerative neurological diseases.

In the language of Computer Science, the two approaches can be contrasted as follows:

• Blumberg = Large-scale log scanning: An approach to searching through an entire system's logs to find anomalous patterns. It doesn't know exactly what to look for in advance, but it identifies areas with statistical anomalies.
• Gajdusek = Deep dive into a specific unresolved incident: An approach where you take one known, unusual case and thoroughly investigate its cause. The type of cause may be new.

The Landscape of the Time: A Year of Great Upheaval

1976 was a year of major upheaval on many fronts.

In world history, July 4th marked the grand celebration of the 200th anniversary of the United States. On September 9th, Mao Zedong died, effectively ending the Cultural Revolution. This paved the way for Deng Xiaoping's reforms. On July 28th, the Tangshan earthquake struck China, killing 240,000 people and becoming one of the worst natural disasters of the 20th century. It also spurred advancements in anti-earthquake technology.

In Korean history, August 18th saw the Panmunjom axe incident, where two U.S. officers were killed by North Korean soldiers with axes. The ensuing U.S. counter-operation (Operation Paul Bunyan) escalated the crisis, which was eventually defused when Kim Il-sung expressed regret. At the same time, under the Yushin Constitution, the 3.1 Democratic National Salvation Declaration by opposition and dissident figures was underway, along with the subsequent trial.

In this year of upheaval, the Nobel Committee recognized the discovery of two new pathogens. It was a year in which new pathogens were discovered in the small systems of the body while the large systems (politics) were being shaken up.

Blumberg: The Navigator of Large-Scale Serum Scans

Baruch S. Blumberg (1925– ) is an American virologist. His life story is one of the most moving of the entire award.

He was born in New York City, USA, in 1925, studied at Columbia University and Oxford University, and served as a professor at the University of Pennsylvania from 1964. He was appointed the Fox Chase Endowed Chair Professor from 1989 and became the Chief of the Fox Chase Cancer Center, and — remarkably — from 1999 to 2004 he even served as the Director of the NASA Astrobiology Institute.

It is a unique career path for a virologist to become the director of the NASA Astrobiology Institute. Astrobiology, which explores the possibility of life beyond Earth, has a similar approach and mindset to population scanning — exploring a broad range to find anomalous patterns.

The same wide-ranging temperament shows up in his hobbies and background. Because he served in the Navy while attending university, he spent a lot of time at sea, and after his discharge he continued to enjoy sailing whenever he faced a major decision or was preparing for a big undertaking. Marathon running, squash, canoeing, and mountaineering were also part of his slate of hobbies. A crucial formative experience was the several months he spent volunteering in a remote mining area in northern Suriname, Africa, during his third and fourth years of medical school, from which he gained his early insights into the prevention and treatment of tropical diseases. He then worked at Bellevue Hospital in New York from 1951 to 1953, and during that period he committed himself to the path of a medical researcher aiming at disease prevention and treatment.

His experience volunteering in Africa during medical school sparked his interest in tropical infectious diseases, which led to his comparative study of serum from various populations. It's a trajectory from doctor to researcher conducting large-scale population scans.

The Decisive Discovery: Australian Antigen and Hepatitis B

Blumberg's original goal was to investigate the genetic polymorphisms of various races and ethnic groups. He conducted a large-scale scan to see which serum antigens differed among population groups.

In 1964, a pivotal moment: He discovered an antigen in the serum of Australian aborigines that reacted uniquely with antibodies from American blood bank donors. He named it the "Australian antigen". At first, the medical significance of this antigen was unknown.

In 1967, a crucial connection: He revealed that this antigen was related to hepatitis B virus. The Australian antigen was the surface protein (HBsAg, hepatitis B surface antigen) of the hepatitis B virus. Once this connection was established, the Australian antigen took hold as the standard marker for screening blood that could transmit hepatitis B.

This discovery fundamentally changed the safety of blood banks. Prior to this, hepatitis B transmission after blood transfusions was a major problem, but the Australian antigen test allowed for the screening of infected blood, significantly reducing the incidence of post-transfusion infections.

The subsequent expansion of the discovery ran as follows. Blumberg analyzed the distribution of HBV within the human population and showed empirically that individuals who appear outwardly healthy can nonetheless carry HBV and transmit the virus to others.

This established the concept of the chronic hepatitis B carrier. It revealed that there are individuals who appear healthy but are in a chronic state of infection. This has significant implications for public health policy.

Gajdusek: The Mountain Tribes of New Guinea and Kuru

D. Carleton Gajdusek (1923– ) is an American virologist. He received his M.D. from Harvard University (1946) and was a researcher at the National Institutes of Health (NIH) from 1958.

Gajdusek's pivotal discovery was kuru, a unique neurodegenerative disease that occurs only in the mountain tribes of New Guinea. This disease is a strange disease that occurs only in this tribe, progresses slowly over several years, and eventually leads to death.

Gajdusek lived with this tribe and observed the epidemiology of the disease. It was particularly prevalent in women and children, but rare in adult men. This pattern was a crucial clue.

The decisive discovery: the cause was their funeral practices. The tribe had a custom of women and children eating the brains of deceased relatives, and the disease was transmitted through this practice. The infectious material in the brain tissue was transmitted to the brains of others, causing the disease to develop slowly.

The infection takes several to tens of years to develop — this is precisely the "slow-acting virus" behavior noted earlier. This characteristic made it difficult to determine that the practice was the source of infection. He observed that new cases disappeared in the generation that did not practice the custom (those born after the custom was banned in the 1950s) and concluded that the custom was the cause.

Infection without inflammation was another decisive peculiarity here. Slow-acting viruses cause a variety of chronic degenerative diseases, but crucially they do not accompany an inflammatory response — a feature that clearly sets them apart from other viral infections.

This characteristic was particularly unusual. Typical viral infections cause strong inflammation, but kuru did not. Later, it was discovered that this disease was not actually a virus but a prion — an infectious protein. Stanley Prusiner received the Nobel Prize in 1997 for this discovery.

In other words, Gajdusek's discovery of the "slow-acting virus" was the prelude to the concept of prions. Today, we understand diseases such as bovine spongiform encephalopathy (mad cow disease), Creutzfeldt-Jakob disease (CJD), and scrapie because of this.

Two Approaches: Population Scanning vs. Deep Investigation

The two researchers' approaches are in contrast.

Blumberg's population scanning:

• Collect data from a wide range: A large number of serum samples from various races and ethnic groups.
• Search for anomalous patterns: Identify statistically unusual reactions.
• Identify the cause of the disease later: Investigate which disease the discovered antigen is related to.
• Strength: Can make discoveries without a pre-existing hypothesis. Open to unexpected discoveries.
• Weakness: Requires large amounts of data and the difficulty of interpreting statistical signals.

Gajdusek's deep investigation:

• Focus on a specific unsolved case: Focus on kuru in New Guinea.
• In-depth observation in the field: Live with the tribe and observe.
• Infer the cause from epidemiological patterns: High incidence in women and children → related to the custom → identify the transmission route.
• Strength: Deep understanding of a specific case. Can discover new types of pathogens.
• Weakness: Focused on a single case, making generalization difficult.

In the language of Computer Science, these two approaches correspond exactly to large-scale log analysis vs. deep incident analysis. Both methods are needed in software operation — large-scale log scanning to detect anomalous patterns, and deep investigation of specific detected issues to identify the root cause. Blumberg and Gajdusek demonstrated the effectiveness of these two methods.

Limitations of the analogy: Of course, population scanning and deep investigation are not mutually exclusive but complementary. Neither one is sufficient on its own, and they must be combined to be powerful. Today, infectious disease control uses a combination of these two approaches.

A Legacy That Continues Today

The Impact of Blumberg's Discovery:

• Hepatitis B Vaccine (1981): The Australia antigen (HBsAg) became the target for the vaccine. Today, it's a mandatory vaccine for newborns. Hundreds of millions of people are vaccinated annually worldwide.
• Prevention of Liver Cancer Related to Hepatitis B: It was discovered that chronic hepatitis B is a major cause of hepatocellular carcinoma, and a vaccine was developed to prevent it. This is the precursor to the world's first cancer-preventing vaccine.
• Standard Screening of Blood Banks: Screening donated blood for HBsAg is now standard practice, significantly reducing the risk of infection after blood transfusions.
• Mapping the Prevalence of Viral Infections by Country: Understanding the chronic infection rate in different populations forms the basis for public health policy.

The Impact of Gajdusek's Discovery:

• Understanding Prions and Prusiner's Nobel Prize (1997): Prusiner later discovered that the cause of kuru was prions.
• Response to Mad Cow Disease (1996 onwards): It was confirmed that bovine spongiform encephalopathy (BSE) in the UK was causing human infection (variant Creutzfeldt-Jakob Disease), leading to a fundamental redesign of the agricultural and blood transfusion policies. Gajdusek's concept of delayed infection was the foundation for this response.
• Research on Alzheimer's and Parkinson's Diseases: These neurodegenerative diseases also share similarities with prion diseases in that the abnormal accumulation of specific proteins is the cause. This is the methodological foundation for research in this area.
• Medical Anthropology of Indigenous Tribes: Gajdusek's in-depth, on-site investigation methods became the standard for research on various diseases in indigenous populations.

Why is it Important?

What these two individuals left behind is proof that "there is more than one way to approach discovery."

Blumberg's discovery of an antigen during a large-scale screening, and Gajdusek's discovery of a culturally-transmitted infection while living among a tribe—these two contrasting approaches each led to groundbreaking discoveries. This is the foundation of the perspective we take for granted today—that "there are many valid approaches to discovery."

The story of how the discovery of the Australia antigen led to the world's first cancer-preventing vaccine (for hepatitis B) highlights the special significance of this award. The concept that preventing infectious diseases can also prevent cancer was one of the fundamental shifts in public health in the late 20th century. The prevention of cervical cancer through the HPV vaccine (21st century) is an extension of this concept.

The story of how living with the New Guinea tribe and discovering the cause of kuru led to the expansion of the prion concept and became the foundation for responding to mad cow disease—demonstrates how a single, unique case can become the basis for responding to a global public health crisis half a century later.

Physicians, veterinarians, blood transfusion policy officials, vaccine developers, and public health experts all use the knowledge that originated from these two individuals in their daily work.

Blumberg and Gajdusek in 1976: A Summary: Blumberg discovered the Australia antigen (HBsAg, hepatitis B virus surface antigen) during a large-scale screening of human serum. Gajdusek discovered that kuru, a disease affecting the Fore tribe of New Guinea, was a culturally-transmitted infection and established the concept of delayed infection. These discoveries are the theoretical roots of the hepatitis B vaccine, liver cancer prevention, the understanding of prions, and the response to mad cow disease today.

→ Previous: 1975 — Baltimore, Dulbecco, Temin → Next: 1977 — Guillemin, Schally, and Yalow